Literature DB >> 33648584

A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report.

Soheila Aminimoghaddam1, Narjes Afrooz2, Setare Nasiri2, Ozra Motaghi Nejad2, Fatemeh Mahmoudzadeh3.   

Abstract

BACKGROUND: Pregnancy seems to increase the risk of thrombotic thrombocytopenic purpura (TTP) relapses and make the TTP more severe in any of the pregnancy trimesters, or even during the postpartum period. CASE
PRESENTATION: This study highlights details of treating a COVID-19 pregnant patient who survived. This 21-year addicted White woman was admitted at her 29th week and delivered a stillbirth. She was transferred to another hospital after showing signs of TTP, which was caused by a viral infection.
CONCLUSION: This viral infection caused fever and dyspnea, and the patient was tested positive for COVID-19 infection. A chest computed tomography scan showed diffuse multiple bilateral consolidations and interlobar septal thickening. She stayed at the Intensive Care Unit for 20 days and treated with plasmapheresis. As far as we know, this is the first report of a TTP pregnant patient with COVID-19 infection.

Entities:  

Keywords:  Addiction; COVID-19; Plasmapheresis; Pregnancy; Thrombotic thrombocytopenic purpura

Year:  2021        PMID: 33648584     DOI: 10.1186/s13256-020-02577-5

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  7 in total

1.  Eculizumab for atypical hemolytic uremic syndrome in pregnancy.

Authors:  Gianluigi Ardissino; Manuela Wally Ossola; Giulia Maria Baffero; Angelo Rigotti; Massimo Cugno
Journal:  Obstet Gynecol       Date:  2013-08       Impact factor: 7.661

2.  von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women.

Authors:  Analía Sánchez-Luceros; Cristina E Farías; María M Amaral; Ana C Kempfer; Roberto Votta; Carlos Marchese; María J Salviú; Adriana I Woods; Susana S Meschengieser; María A Lazzari
Journal:  Thromb Haemost       Date:  2004-12       Impact factor: 5.249

3.  Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.

Authors:  Rahel Froehlich-Zahnd; James N George; Sara K Vesely; Deirdra R Terrell; Khatira Aboulfatova; Jing-Fei Dong; Brenda M Luken; Jan Voorberg; Ulrich Budde; Irmela Sulzer; Bernhard Lämmle; Johanna A Kremer Hovinga
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

4.  Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19.

Authors:  Ying Liu; Min Li; Dan Liu; Jian Fei Luo; Nian Li; Xuan Zhang; Xiao Ju Tang; Xin Zhang; Jia Liu; Ji Wang; Ting Wang; Yong Zao Zhou; Wen Xin Luo; Zong An Liang; Feng Ming Luo; Wei Min Li; Gang Wang
Journal:  J Infect       Date:  2020-12-31       Impact factor: 6.072

5.  Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated With Pulse Taper Corticosteroids for Post-infectious Inflammatory Syndrome.

Authors:  Seher Anjum; Owen Dean; Peter Kosa; M Teresa Magone; Kelly A King; Edmond Fitzgibbon; H Jeff Kim; Chris Zalewski; Elizabeth Murphy; Bridgette Jeanne Billioux; Jennifer Chisholm; Carmen C Brewer; Chantal Krieger; Waleed Elsegeiny; Terri L Scott; Jing Wang; Sally Hunsberger; John E Bennett; Avindra Nath; Kieren A Marr; Bibiana Bielekova; David Wendler; Dima A Hammoud; Peter Williamson
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

6.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.

Authors:  Huijun Chen; Juanjuan Guo; Chen Wang; Fan Luo; Xuechen Yu; Wei Zhang; Jiafu Li; Dongchi Zhao; Dan Xu; Qing Gong; Jing Liao; Huixia Yang; Wei Hou; Yuanzhen Zhang
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

7.  WITHDRAWN: Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings.

Authors:  Parisa Karami; Maliheh Naghavi; Abdolamir Feyzi; Mehdi Aghamohammadi; Mohammad Sadegh Novin; Ahmadreza Mobaien; Mohamad Qorbanisani; Aida Karami; Amir Hossein Norooznezhad
Journal:  Travel Med Infect Dis       Date:  2020-04-11       Impact factor: 6.211

  7 in total
  5 in total

1.  Coronavirus Disease 2019-Associated Thrombotic Microangiopathy.

Authors:  Marija Malgaj Vrecko; Zeljka Veceric-Haler
Journal:  J Hematol       Date:  2022-08-30

2.  Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.

Authors:  Fei Fang; Brandon Tse; Katerina Pavenski
Journal:  BMJ Case Rep       Date:  2022-07-28

3.  A Race against the Clock: A Case Report and Literature Review Concerning the Importance of ADAMTS13 Testing in Diagnosis and Management of Thrombotic Thrombocytopenic Purpura during Pregnancy.

Authors:  Melinda Ildiko Mitranovici; Lucian Pușcașiu; Ioan Emilian Oală; Izabella Petre; Marius Lucian Craina; Antonia Rebeka Mager; Kinga Vasile; Diana Maria Chiorean; Adrian-Horațiu Sabău; Sabin Gligore Turdean; Ovidiu Simion Cotoi
Journal:  Diagnostics (Basel)       Date:  2022-06-27

Review 4.  Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review.

Authors:  Marija Malgaj Vrečko; Andreja Aleš Rigler; Željka Večerić-Haler
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

5.  Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

Authors:  Donald C Vinh; Laurent Abel; Paul Bastard; Matthew P Cheng; Antonio Condino-Neto; Peter K Gregersen; Filomeen Haerynck; Maria-Pia Cicalese; David Hagin; Pere Soler-Palacín; Anna M Planas; Aurora Pujol; Luigi D Notarangelo; Qian Zhang; Helen C Su; Jean-Laurent Casanova; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-06-08       Impact factor: 8.542

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.